title: Radiation as a therapeutic modality in sarcomas of the soft tissue.
abstract: Management of the primary lesion in patients with soft tissue sarcomas is combined modality in the majority of instances. The modalities are surgery and irradiation. Radical surgery as currently practiced in major oncology centers does not achieve local control in an important proportion of patients.
mesh_terms: D000206:Actuarial Analysis; D000818:Animals; D001918:Brachytherapy / Q000009:adverse effects / Q000379:methods; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004283:Dog Diseases / Q000532:radiotherapy; D004285:Dogs; D018222:Desmoid Tumors / Q000532:radiotherapy; D006801:Humans; D051379:Mice; D008809:Mice, Inbred C3H; D011836:Radiation Tolerance; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use; D011867:Radioisotope Teletherapy / Q000379:methods; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D012509:Sarcoma / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery / Q000662:veterinary; D012513:Sarcoma, Experimental / Q000532:radiotherapy / Q000601:surgery; D012983:Soft Tissue Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery / Q000662:veterinary; D016896:Treatment Outcome; D014407:Tumor Cells, Cultured / Q000528:radiation effects; D014945:Wound Healing / Q000528:radiation effects
chemical_list: D011838:Radiation-Sensitizing Agents